Oscar Health (OSCR) Shares Outstanding (Weighted Average) (2020 - 2026)

Oscar Health has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $298.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 18.67% year-over-year to $298.2 million; the trailing twelve-month figure through Mar 2026 stood at $298.2 million (up 18.67% YoY), and the FY2025 full-year result was $262.4 million, up 9.15% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $298.2 million, up from $262.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $298.2 million in Q1 2026, with the low at $210.5 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $235.0 million across 5 years, with a median of $231.4 million in 2024.
• The largest YoY upside for Shares Outstanding (Weighted Average) was 136.93% in 2022 against a maximum downside of 2.24% in 2022.
• Oscar Health's Shares Outstanding (Weighted Average) stood at $212.5 million in 2022, then rose by 4.32% to $221.7 million in 2023, then gained by 8.45% to $240.4 million in 2024, then increased by 9.15% to $262.4 million in 2025, then climbed by 13.64% to $298.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $298.2 million (Q1 2026), $262.4 million (Q4 2025), and $255.4 million (Q3 2025), per Business Quant data.